Free Trial

Patterson Companies (PDCO) Competitors

Patterson Companies logo
$31.32 -0.03 (-0.08%)
As of 10:51 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PDCO vs. HSIC, OMI, MCK, COR, CAH, RDY, AVTR, PEN, MRNA, and EXEL

Should you be buying Patterson Companies stock or one of its competitors? The main competitors of Patterson Companies include Henry Schein (HSIC), Owens & Minor (OMI), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Dr. Reddy's Laboratories (RDY), Avantor (AVTR), Penumbra (PEN), Moderna (MRNA), and Exelixis (EXEL). These companies are all part of the "medical" sector.

Patterson Companies vs.

Henry Schein (NASDAQ:HSIC) and Patterson Companies (NASDAQ:PDCO) are both mid-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation, community ranking and risk.

In the previous week, Henry Schein had 11 more articles in the media than Patterson Companies. MarketBeat recorded 26 mentions for Henry Schein and 15 mentions for Patterson Companies. Patterson Companies' average media sentiment score of 1.02 beat Henry Schein's score of 0.90 indicating that Patterson Companies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Henry Schein
13 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Positive
Patterson Companies
8 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Henry Schein currently has a consensus target price of $81.10, indicating a potential upside of 25.58%. Patterson Companies has a consensus target price of $26.57, indicating a potential downside of 15.15%. Given Henry Schein's stronger consensus rating and higher possible upside, analysts plainly believe Henry Schein is more favorable than Patterson Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Henry Schein
0 Sell rating(s)
5 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.64
Patterson Companies
0 Sell rating(s)
10 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.09

Henry Schein has a net margin of 2.51% compared to Patterson Companies' net margin of 2.37%. Patterson Companies' return on equity of 19.77% beat Henry Schein's return on equity.

Company Net Margins Return on Equity Return on Assets
Henry Schein2.51% 12.90% 5.21%
Patterson Companies 2.37%19.77%6.66%

Henry Schein has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Comparatively, Patterson Companies has a beta of 0.73, suggesting that its stock price is 27% less volatile than the S&P 500.

Henry Schein has higher revenue and earnings than Patterson Companies. Patterson Companies is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Henry Schein$12.67B0.63$416M$3.0421.24
Patterson Companies$6.51B0.43$185.93M$1.5420.33

Henry Schein received 18 more outperform votes than Patterson Companies when rated by MarketBeat users. Likewise, 51.70% of users gave Henry Schein an outperform vote while only 50.14% of users gave Patterson Companies an outperform vote.

CompanyUnderperformOutperform
Henry ScheinOutperform Votes
380
51.70%
Underperform Votes
355
48.30%
Patterson CompaniesOutperform Votes
362
50.14%
Underperform Votes
360
49.86%

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 85.4% of Patterson Companies shares are owned by institutional investors. 1.1% of Henry Schein shares are owned by company insiders. Comparatively, 1.9% of Patterson Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Henry Schein beats Patterson Companies on 15 of the 19 factors compared between the two stocks.

Remove Ads
Get Patterson Companies News Delivered to You Automatically

Sign up to receive the latest news and ratings for PDCO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PDCO vs. The Competition

MetricPatterson CompaniesMedical & hospital equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$2.77B$7.86B$5.36B$7.63B
Dividend Yield3.34%1.98%5.11%4.33%
P/E Ratio18.3121.1821.7617.88
Price / Sales0.431.19381.6595.73
Price / Cash9.1710.7638.1534.64
Price / Book2.802.106.484.02
Net Income$185.93M$259.21M$3.20B$247.22M
7 Day Performance0.82%-0.95%6.97%7.00%
1 Month Performance0.56%-8.15%-8.33%-6.42%
1 Year Performance23.53%-10.70%10.06%-0.03%

Patterson Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PDCO
Patterson Companies
3.3604 of 5 stars
$31.32
-0.1%
$26.57
-15.2%
+23.1%$2.77B$6.51B18.317,700Analyst Forecast
Short Interest ↑
Analyst Revision
News Coverage
Positive News
HSIC
Henry Schein
3.4845 of 5 stars
$64.31
-1.8%
$81.10
+26.1%
-7.6%$7.99B$12.67B26.4722,000Analyst Revision
Gap Down
OMI
Owens & Minor
4.7963 of 5 stars
$8.13
-0.4%
$13.75
+69.2%
-72.9%$627.63M$10.70B-12.5013,700Gap Down
MCK
McKesson
4.5841 of 5 stars
$661.26
-3.2%
$661.00
0.0%
+32.7%$82.87B$344.58B30.2875,000Positive News
High Trading Volume
COR
Cencora
4.2046 of 5 stars
$274.60
-1.4%
$280.20
+2.0%
+21.5%$53.25B$638.56M39.0642,000Positive News
CAH
Cardinal Health
4.6265 of 5 stars
$125.74
-3.0%
$140.14
+11.5%
+28.2%$30.37B$222.28B23.4646,500Short Interest ↓
Positive News
High Trading Volume
RDY
Dr. Reddy's Laboratories
3.373 of 5 stars
$12.59
+1.8%
$17.00
+35.1%
-7.2%$10.51B$311.31B20.0424,800Positive News
High Trading Volume
AVTR
Avantor
4.7367 of 5 stars
$15.25
+0.8%
$25.50
+67.2%
-37.7%$10.39B$6.78B14.6614,500Positive News
Gap Down
PEN
Penumbra
3.8558 of 5 stars
$263.59
+0.5%
$294.47
+11.7%
+24.5%$10.15B$1.19B775.253,900Short Interest ↑
MRNA
Moderna
4.3359 of 5 stars
$25.64
+2.1%
$59.00
+130.1%
-74.5%$9.91B$3.20B-2.763,900Gap Down
EXEL
Exelixis
4.2549 of 5 stars
$34.84
+0.8%
$37.59
+7.9%
+56.7%$9.75B$2.17B19.681,220Positive News
Gap Down
Remove Ads

Related Companies and Tools


This page (NASDAQ:PDCO) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners